Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Beyond the flat screen: evaluating virtual reality as a complementary tool for molecular docking in drug discovery.

Created on 18 Oct 2026

Authors

Viktoria A Feoktistova, Korney Aruko, Ekaterina V Skorb, Sergey Shityakov

Published in

Journal of computer-aided molecular design. Volume 40. Issue 1. Aug 24, 2026. Epub Aug 24, 2026.

Abstract

Molecular docking is a key computational approach in drug discovery and structural biology. Traditional docking tools, while effective for high-throughput screening, often rely on rigid or semiflexible receptor models and purely algorithmic sampling, limiting accurate modeling of induced-fit effects and dynamic binding pathways. Virtual reality (VR) platforms introduce a human-in-the-loop approach, enabling immersive 3D visualization, improved spatial perception of molecular interactions, and intuitive manipulation of ligands and flexible receptor regions. In addition, collaborative VR environments allow multiple researchers to interact with the same molecular model simultaneously while working remotely, potentially enhancing communication and interdisciplinary cooperation. Despite these advantages, several challenges continue to limit the widespread adoption of VR-assisted docking. This critical review compares classical and VR-based molecular docking approaches, focusing on their respective capabilities, advantages, and current limitations.

PMID:
42637961
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement